Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2J15

Cyclic MrIA: An exceptionally stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter.

Summary for 2J15
Entry DOI10.2210/pdb2j15/pdb
NMR InformationBMRB: 7341
DescriptorMAI126P (1 entity in total)
Functional Keywordstoxin
Biological sourceCONUS MARMOREUS
Total number of polymer chains1
Total formula weight1542.83
Authors
Lovelace, E.S.,Armishaw, C.J.,Colgrave, M.L.,Walstrom, M.E.,Alewood, P.F.,Daly, N.L.,Craik, D.J. (deposition date: 2006-08-09, release date: 2006-11-01, Last modification date: 2025-04-09)
Primary citationLovelace, E.S.,Armishaw, C.J.,Colgrave, M.L.,Wahlstrom, M.E.,Alewood, P.F.,Daly, N.L.,Craik, D.J.
Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter.
J. Med. Chem., 49:6561-6568, 2006
Cited by
PubMed Abstract: Conotoxins, disulfide-rich peptides from the venom of cone snails, have created much excitement over recent years due to their potency and specificity for ion channels and their therapeutic potential. One recently identified conotoxin, MrIA, a 13-residue member of the chi-conotoxin family, inhibits the human norepinephrine transporter (NET) and has potential applications in the treatment of pain. In the current study, we show that the beta-hairpin structure of native MrIA is retained in a synthetic cyclic version, as is biological activity at the NET. Furthermore, the cyclic version has increased resistance to trypsin digestion relative to the native peptide, an intriguing result because the cleavage site for the trypsin is not close to the cyclization site. The use of peptides as drugs is generally hampered by susceptibility to proteolysis, and so, the increase in enzymatic stability against trypsin observed in the current study may be useful in improving the therapeutic potential of MrIA. Furthermore, the structure reported here for cyclic MrIA represents a new topology among a growing number of circular disulfide-rich peptides.
PubMed: 17064074
DOI: 10.1021/jm060299h
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon